214 related articles for article (PubMed ID: 21643982)
1. Alterations of ATM and CADM1 in chromosomal 11q22.3-23.2 region are associated with the development of invasive cervical carcinoma.
Mazumder Indra D; Mitra S; Roy A; Mondal RK; Basu PS; Roychoudhury S; Chakravarty R; Panda CK
Hum Genet; 2011 Dec; 130(6):735-48. PubMed ID: 21643982
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of CHEK1 and EI24 is associated with the development of invasive cervical carcinoma: clinical and prognostic implications.
Mazumder Indra D; Mitra S; Singh RK; Dutta S; Roy A; Mondal RK; Basu PS; Roychoudhury S; Panda CK
Int J Cancer; 2011 Oct; 129(8):1859-71. PubMed ID: 21154811
[TBL] [Abstract][Full Text] [Related]
3. Methylation of Cervical Neoplastic Cells Infected With Human Papillomavirus 16.
Ki EY; Lee KH; Hur SY; Rhee JE; Kee MK; Kang C; Park JS
Int J Gynecol Cancer; 2016 Jan; 26(1):176-83. PubMed ID: 26552048
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal signatures of a subset of high-grade premalignant cervical lesions closely resemble invasive carcinomas.
Wilting SM; Steenbergen RD; Tijssen M; van Wieringen WN; Helmerhorst TJ; van Kemenade FJ; Bleeker MC; van de Wiel MA; Carvalho B; Meijer GA; Ylstra B; Meijer CJ; Snijders PJ
Cancer Res; 2009 Jan; 69(2):647-55. PubMed ID: 19147580
[TBL] [Abstract][Full Text] [Related]
5. Alterations of RASSF1A in premalignant cervical lesions: clinical and prognostic significance.
Mitra S; Mazumder Indra D; Basu PS; Mondal RK; Roy A; Roychoudhury S; Panda CK
Mol Carcinog; 2012 Sep; 51(9):723-33. PubMed ID: 21809394
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of the tumor-suppressor cell adhesion molecule 1 in human papillomavirus-transformed cervical carcinoma cells.
Woo HJ; Kim SJ; Song KJ; Kim SS; Yoon CH; Choi BS; Rhee JE
Int J Oncol; 2015; 46(6):2656-62. PubMed ID: 25845528
[TBL] [Abstract][Full Text] [Related]
7. Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1/MAL methylation analysis on cervical scrapes.
Verhoef VM; van Kemenade FJ; Rozendaal L; Heideman DA; Bosgraaf RP; Hesselink AT; Melchers WJ; Massuger LF; Bekkers RL; Steenbergen RD; Berkhof J; Snijders PJ; Meijer CJ
Gynecol Oncol; 2015 Apr; 137(1):55-9. PubMed ID: 25667975
[TBL] [Abstract][Full Text] [Related]
8. CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease.
Bierkens M; Hesselink AT; Meijer CJ; Heideman DA; Wisman GB; van der Zee AG; Snijders PJ; Steenbergen RD
Int J Cancer; 2013 Sep; 133(6):1293-9. PubMed ID: 23456988
[TBL] [Abstract][Full Text] [Related]
9. CADM1 and MAL methylation status in cervical scrapes is representative of the most severe underlying lesion in women with multiple cervical biopsies.
van Baars R; van der Marel J; Snijders PJ; Rodriquez-Manfredi A; ter Harmsel B; van den Munckhof HA; Ordi J; del Pino M; van de Sandt MM; Wentzensen N; Meijer CJ; Quint WG
Int J Cancer; 2016 Jan; 138(2):463-71. PubMed ID: 26219541
[TBL] [Abstract][Full Text] [Related]
10. Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC.
Overmeer RM; Henken FE; Snijders PJ; Claassen-Kramer D; Berkhof J; Helmerhorst TJ; Heideman DA; Wilting SM; Murakami Y; Ito A; Meijer CJ; Steenbergen RD
J Pathol; 2008 Aug; 215(4):388-97. PubMed ID: 18498117
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms and cervical cancer development: ATM G5557A and p53bp1 C1236G.
Oliveira S; Ribeiro J; Sousa H; Pinto D; Baldaque I; Medeiros R
Oncol Rep; 2012 Apr; 27(4):1188-92. PubMed ID: 22200742
[TBL] [Abstract][Full Text] [Related]
12. The Role of
Holubekova V; Mersakova S; Grendar M; Snahnicanova Z; Kudela E; Kalman M; Lasabova Z; Danko J; Zubor P
Genet Test Mol Biomarkers; 2020 May; 24(5):256-263. PubMed ID: 32311274
[No Abstract] [Full Text] [Related]
13. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
Steenbergen RD; Kramer D; Braakhuis BJ; Stern PL; Verheijen RH; Meijer CJ; Snijders PJ
J Natl Cancer Inst; 2004 Feb; 96(4):294-305. PubMed ID: 14970278
[TBL] [Abstract][Full Text] [Related]
14. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women.
Hesselink AT; Heideman DA; Steenbergen RD; Coupé VM; Overmeer RM; Rijkaart D; Berkhof J; Meijer CJ; Snijders PJ
Clin Cancer Res; 2011 Apr; 17(8):2459-65. PubMed ID: 21389098
[TBL] [Abstract][Full Text] [Related]
15. Analysis of 11q21-24 loss of heterozygosity candidate target genes in breast cancer: indications of TSLC1 promoter hypermethylation.
Allinen M; Peri L; Kujala S; Lahti-Domenici J; Outila K; Karppinen SM; Launonen V; Winqvist R
Genes Chromosomes Cancer; 2002 Aug; 34(4):384-9. PubMed ID: 12112527
[TBL] [Abstract][Full Text] [Related]
16. RBSP3 is frequently altered in premalignant cervical lesions: clinical and prognostic significance.
Mitra S; Mazumder Indra D; Bhattacharya N; Singh RK; Basu PS; Mondal RK; Roy A; Zabarovsky ER; Roychoudhury S; Panda CK
Genes Chromosomes Cancer; 2010 Feb; 49(2):155-70. PubMed ID: 19885927
[TBL] [Abstract][Full Text] [Related]
17. Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women.
Overmeer RM; Louwers JA; Meijer CJ; van Kemenade FJ; Hesselink AT; Daalmeijer NF; Wilting SM; Heideman DA; Verheijen RH; Zaal A; van Baal WM; Berkhof J; Snijders PJ; Steenbergen RD
Int J Cancer; 2011 Nov; 129(9):2218-25. PubMed ID: 21190187
[TBL] [Abstract][Full Text] [Related]
18. Association of P16-RBSP3 inactivation with phosphorylated RB1 overexpression in basal-parabasal layers of normal cervix unchanged during CACX development.
Chakraborty C; Roychowdhury A; Samadder S; Roy A; Mandal RK; Basu P; Roychoudhury S; Panda CK
Biochem J; 2016 Oct; 473(19):3221-36. PubMed ID: 27458253
[TBL] [Abstract][Full Text] [Related]
19. Performance of CADM1/MAL-methylation analysis for monitoring of women treated for high-grade CIN.
Uijterwaal MH; van Zummeren M; Kocken M; Luttmer R; Berkhof J; Witte BI; van Baal WM; Graziosi GCM; Verheijen RHM; Helmerhorst TJM; van Dijken DKE; Spruijt JWM; van Kemenade FJ; Fransen-Daalmeijer N; Bekker-Lettink M; Heideman DAM; Snijders PJF; Steenbergen RDM; Meijer CJLM
Gynecol Oncol; 2016 Oct; 143(1):135-142. PubMed ID: 27430395
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of LIMD1-VHL-HIF-1α-VEGF pathway is associated with different stages of cervical cancer.
Chakraborty C; Mitra S; Roychowdhury A; Samadder S; Dutta S; Roy A; Das P; Mandal RK; Sharp TV; Roychoudhury S; Panda CK
Biochem J; 2018 May; 475(10):1793-1806. PubMed ID: 29654110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
